| 1 |
Tardive dyskinesia |
|
|
| Soares-Weiser K, Fernandez HH |
|
| SEMINARS IN NEUROLOGY. 2007; 27 (2): 159-169 |
|
| [Pubmed] [Google Scholar] |
|
| 2 |
Extrapyramidal symptoms with atypical antipsychotics - Incidence, prevention and management |
|
|
| Pierre JM |
|
| DRUG SAFETY. 2005; 28 (3): 191-208 |
|
| [Pubmed] [Google Scholar] |
|
| 3 |
Vitamin E supplementation in Alzheimers disease, Parkinsons disease, tardive dyskinesia, and cataract: Part 2 |
|
|
| Pham DQ, Plakogiannis R |
|
| ANNALS OF PHARMACOTHERAPY. 2005; 39 (12): 2065-2072 |
|
| [Pubmed] [Google Scholar] |
|
| 4 |
Oxidative mechanisms and tardive dyskinesia |
|
|
| Lohr JB, Kuczenski R, Niculescu AB |
|
| CNS DRUGS. 2003; 17 (1): 47-62 |
|
| [Pubmed] [Google Scholar] |
|
| 5 |
Tardive dyskinesia: Possible involvement of free radicals and treatment with vitamin E |
|
|
| Elkashef AM, Wyatt RJ |
|
| SCHIZOPHRENIA BULLETIN. 1999; 25 (4): 731-740 |
|
| [Pubmed] [Google Scholar] |
|
| 6 |
The treatment of tardive dyskinesia - a systematic review and meta-analysis |
|
|
| Soares KVS, McGrath JJ |
|
| SCHIZOPHRENIA RESEARCH. 1999; 39 (1): 1-16 |
|
| [Pubmed] [Google Scholar] |
|
| 7 |
Vitamin E in the treatment of tardive dyskinesia |
|
|
| Boomershine KH, Shelton PS, Boomershine JE |
|
| ANNALS OF PHARMACOTHERAPY. 1999; 33 (11): 1195-1202 |
|
| [Pubmed] [Google Scholar] |
|
| 8 |
High-dose vitamin E plus vitamin B-6 treatment of risperidone-related neuroleptic malignant syndrome |
|
|
| Dursun SM, Oluboka OJ, Devarajan S, et al. |
|
| JOURNAL OF PSYCHOPHARMACOLOGY. 1998; 12 (2): 220-221 |
|
| [Pubmed] [Google Scholar] |
|
| 9 |
Managing antipsychotic-induced acute and tardive dystonia |
|
|
| Raja M |
|
| DRUG SAFETY. 1998; 19 (1): 57-72 |
|
| [Pubmed] [Google Scholar] |
|
| 10 |
Vitamin E (α-Tocopherol) in the Treatment of Tardive Dyskinesia: A Statistical Meta-Analysis |
|
|
| Yoram Barak, Marnina Swartz, Eyal Shamir, et al |
|
| Annals of Clinical Psychiatry. 1998; 10(3): 101-105 |
|
| [Pubmed] [Google Scholar] |
|
| 11 |
Treatment of tardive dyskinesia |
|
|
| Egan, M.F., Apud, J., Wyatt, R.J. |
|
| Schizophrenia Bulletin. 1997; 23(4): 583-609 |
|
| [Pubmed] [Google Scholar] |
|
| 12 |
Clozapine and tardive dyskinesia: Analysis of clinical trials |
|
|
| Wittenberg, N., Stein, D., Barak, Y., Achiron, A. |
|
| Pathophysiology. 1996; 3(4): 241-245 |
|
| [Pubmed] [Google Scholar] |
|
| 13 |
A double-blind placebo-controlled study of vitamin E treatment of tardive dyskinesia |
|
|
| Lohr JB, Caligiuri MP |
|
| JOURNAL OF CLINICAL PSYCHIATRY. 1996; 57 (4): 167-173 |
|
| [Pubmed] [Google Scholar] |
|
| 14 |
Antioxidant treatment of tardive dyskinesia |
|
|
| Rotrosen J, Adler L, Lohr J, et al. |
|
| PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS. 1996; 55 (1-): 77-81 |
|
| [Pubmed] [Google Scholar] |
|
| 15 |
Melatonin, sleep, aging, and the health protection branch |
|
|
| Young SN |
|
| JOURNAL OF PSYCHIATRY & NEUROSCIENCE. 1996; 21 (3): 161-164 |
|
| [Pubmed] [Google Scholar] |
|
